ComplianceOnline

How to Survive a DEA Inspection Series - DEA and Veterinary Medicine

Instructor: Carlos M Aquino
Product ID: 704563
  • Duration: 60 Min
Purchase option for this webinar is currently unavailable. Please contact our Customer Care for more info.

Customer Care

Fax: +1-650-963-2556

Email: customercare@complianceonline.com

Read Frequently Asked Questions

This training program is tailored for practitioners treating pain. It will provide you with a better understanding of a DEA inspection and the records needed in the event of an inquiry by DEA or any state regulatory agency. Participants will familiarize themselves with the federal laws and regulations enforced by DEA pertaining to Schedules II through V controlled substances that is dispensed, or prescribed by a physician as part of a pain treatment plan.

Why Should You Attend:

As a practitioners treating pain, you are required by federal and state laws and regulations to take many steps in order to be assured that the controlled substance you dispensed or prescribed are done with a legitimate medical purpose and are being properly used by the patient.

This training webinar will cover steps that will assist you in order to comply with these laws and regulations. The topics are focused on the patient-practitioner relationship and the necessary information that is needed in a patient chart that may result in a prescription for pain. It will also provide participants with a better understanding of DEA and their record keeping and security requirements.

Webinar participants will familiarize themselves with the federal laws and regulations enforced by DEA pertaining to Schedules II through V controlled substances that is dispensed, or prescribed by a physician as part of a pain treatment plan. Also they will be familiarized with the necessary documentation that should be noted in the patient chart and step to prevent diversion of the dispensed or prescribed drugs.

Learning Objectives:

  • Describe the types of actions that can be imposed by a federal prosecutor’s office on a pain management clinic or practitioners treating pain. This includes the type of fines that can be imposed through a criminal or civil action utilizing the federal laws and regulations pertaining to the administering, dispensing, and prescribing of controlled substances as part of a pain management treatment plan.
  • Identify the steps taken by the DEA in enforcing federal laws and regulations through their Office of Diversion Control who is responsible for all investigation and regulatory actions for Schedules II through V controlled substance especially those dispensed or prescribed as part of a pain management treatment plan.
  • Discuss the importance of a good patient chart that contains all documentation beginning when the patient was initially accepted as a patient to the most recent visit to the clinic or seen by the physician. This includes the patient agreement, the treatment plan, and any controlled substance administered, dispensed or prescribed for the patient.
  • Review all the requirements pertaining to administering, dispensing and prescribing of controlled substance prescription by a physician as part of a pain management treatment plan. The subjects covered will also include electronic prescriptions, the DEA regulation pertaining to a 90-day supply of a Schedule II drug, prescriptions for LTCF and hospice patients, and the use and storage of prescription pads.

Areas Covered in the Webinar:

  • Types of actions that can be imposed by a federal prosecutor’s office on a pain management clinic or practitioners treating pain
  • Steps taken by the DEA in enforcing federal laws and regulations through their Office of Diversion Control
  • Importance of a good patient chart that contains all documentation including the patient agreement, the treatment plan, and any controlled substance administered, dispensed or prescribed for the patient
  • Review all the requirements pertaining to administering, dispensing and prescribing of controlled substance prescription by a physician as part of a pain management treatment plan

Who Will Benefit:

  • All practitioners treating a patient with controlled substances as part of a pain management treatment plans
  • Veterinarian doctors
  • Clinics
  • Hospitals

Instructor Profile:

In January 2009, Carlos M. Aquino founded PharmaDiversion, LLC, as a compliance consulting firm assisting a DEA registrant, who handle controlled substances and regulated chemicals, with compliance of federal laws and regulations that are enforced by DEA through the Office of Diversion Control. This is done through a mock audit and inspection equivalent to a DEA diversion onsite inspection. The firm also provides in-service training on various areas pertaining to compliance with federal laws and DEA regulations for handling controlled substances.

Consultant Carlos M. Aquino brings 36 years of experience on handling illicit and pharmaceutical controlled substances and regulated chemicals. This includes 12 years with the Philadelphia DEA Diversion and 24 years with the Philadelphia Police Department. During the last 10 years, he was assigned to the Philadelphia DEA task force as a street supervisor and an undercover agent investigating the distribution of illicit drugs and the diversion of pharmaceutical drugs.

Topic Background:

The Drug Enforcement Administration (DEA) through their Office of Diversion Control (Diversion) is responsible for enforcing federal laws and DEA regulations pertaining to the administering, dispensing and prescribing of controlled substances by practitioners practicing veterinary medicine in a hospital, clinic or private office.

The Controlled Substances Act requires that veterinarian practicing medicine need to maintain accurate records of any administering, dispensing and prescribing of Schedules II through V controlled substances and those List I regulated chemicals used for treating animals and pets.

Today’s practitioners treating pain need to take the necessary steps to prevent the diversion of prescribed medication to a patients being treated for that pain. These steps are essentials in order to comply with federal laws and DEA regulations and the policies established by the State Medical Board or the Board of Pharmacy.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
ComplianceOnline Medical Device Summit 2017

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed
    Loading